Trial intelligence / Profile preview

TPF Chemotherapy in Pre-treated Metastatic Esophageal Cancer

NCT00209716Phase 2Completed

Sponsor
Hokkaido Gastrointestinal Cancer Study Group
Start
Dec 2003
Primary completion
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of docetaxel in esophageal cancer, sponsored by Hokkaido Gastrointestinal Cancer Study Group. Started Dec 2003; status: completed.

02

Drugs

docetaxel
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on NCT00209716.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00209716.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call